Platelet disorders Flashcards
Bernard soulier clinical/lab features
- Mild to moderate thrombocytopenia
- large platelets
- highly variable bleeding phenotype (mild to severe)
Bernard soulier diagnosis - 1) response to ristocetin 2) response to adenosine and epinephrine
- platelet aggregometry.
- BSS platelets do not agglutinate or aggregate in response to ristocetin
- Prolonged with epinephrine
- normal to adenosine
Bernard soulier management 1) non life threatening bleeding 2) critical bleeding
IF non life threatening bleeding, plt transfusion to goal 30k + antifibrinolytics
Critical bleeding - recombinant factor VIIa
Steps of platelet aggregation
3 A’s
1) Adhesion -adhesion to damaged epithelium. Adhere to collagen, Regulated by Gp1A2A, GP4, GP6
2) Activation ( release contents of alpha and dense granules)
3) Aggregation
Receptor that mediates platelet aggregation
GP2B3A receptor, and through fibrinogen
2 types of platelet granules and contents
- alpha granules contain platelet factor 4, beta thromboglobulin, VWF, fibrinogen, Factor V, VIII, HMWK, albumin,
- dense granules - ATP, ADP, calcium, serotonin, magnesium
PFA negative predictive value
- very high (very good test of all steps of platelet function), essentially rules out platelet function defect
Bernard soulier inheritance pattern
- autosomal recessive
1) Bernard soulier mechanism 2) complex that is deficient
- *abnormal aggregation to ristocetin
- lack of Gp1b/IX complex
General treatment of platelet disorders during acute bleeding episode
- recombinant factor 7
What to be cautious about with platelet transfusion in bernard soulier
alloimmunization (antibodies to Gp1b)
1) grey platelet syndrome mechanism 2) name of gene mutation
- lack of alpha granules secondary NBEAL2 gene mutation
grey platelet syndrome findings on periphearl smear
- large platelets
- platelets appear grey with poo granularity due to lack of alpha granules
**see photo online
grey platelet syndrome sequela to know
- predisposed to myelofibrosis
hermansky pudlak inheritance
autosomal recessive
hermansky pudlak demographics
Puerto rican (pocket of cases)
1) hermansky pudlak mechanism 2) name of gene mutation
Lack of dense granules, defect in HPS1 gene (hermansky pudlak)
hermansky pudlak and platelet studies
- lack of second wave with ADP and epinephrine
- dense granules or decreased on immunofluorescense
hermansky pudlak clinical features
- pulmonary fibrosis
- albinism
- colitis
- neurologic changes (nystagmus)
Quebec platelet disorder inheritance pattern
Autosomal dominant (so multiple family members affected)
Quebec platelet disorder mechanism
- Decrease in alpha granule protein leading to abnormal aggregation w/ epinephrine
- increased urokinase plasminogen (confirm)
Chediak higashi mechanism
- mutation in LYST gene (lysosomal trafficking regulator protein)
*platelet storage defect
Chediak higashi labs
*thrombocytopenia
anemia
neutropenia
Chediak higashi bone marrow biopsy finding
myeloperoxidase inclusion in neutrophils
Chediak higashi clinical features
- immunodeficiences
Chediak higashi treatment
- steroids
- splenectomy
- prophylactic antibiotics
- consideration for transplant
1) glanzman’s thrombasthenia mechanism 2) response to ristocetin
- platelet aggregation defect, abnormal aggregation to collagen and ADP
- *lack of GPIIbIIIa receptor
- no primary wave seen
-
normal aggregation to ristocetin
(opposite to bernard soulier so important to remember)
*GLANZMANN’s = GLOBAL (lack of response to all with exception of ristocetin)